Tumor Radiomic Features on Pretreatment MRI to Predict Response to Lenvatinib plus an Anti-PD-1 Antibody in Advanced Hepatocellular Carcinoma: A Multicenter Study.
Liver Cancer
; 12(3): 262-276, 2023 Aug.
Article
in En
| MEDLINE
| ID: mdl-37601982
Full text:
1
Database:
MEDLINE
Type of study:
Clinical_trials
/
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Liver Cancer
Year:
2023
Type:
Article
Affiliation country:
China